Bupropion Hydrochloride (XL)
NDC 69097-875, bupropion hydrochloride, tablet, extended release, from CIPLA USA INC.,.
- Product NDC
- 69097-875
- Status
- Listed
- Labeler
- CIPLA USA INC.,
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206556
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-875 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPROPION HYDROCHLORIDE150 mg/1
Pharmacologic classes
Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-875-02 | 69097087502 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-875-02) |
| 69097-875-05 | 69097087505 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-875-05) |
| 69097-875-12 | 69097087512 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-875-12) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c2cf79d7-1aba-4391-980b-5e218781f7c6NADAC price for package 69097087505
GET /v1/drugs/nadac/69097087505
Use it
Look up 69097-875 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-875 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-875. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.